Visara appoints ophthalmology leaders to advance VIS-101 drug program
Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program| (NASDAQ: AURA) | Delayed: 6.18 -0.12 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.30 | 52 Week High | $ | |||
| Open | $6.31 | 52 Week Low | $ | |||
| Day High | $6.42 | P/E | N/A | |||
| Day Low | $6.15 | EPS | $ | |||
| Volume | 907,586 | |||||
| (NASDAQ: FDMT) | Delayed: 11.03 +0.23 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.80 | 52 Week High | $ | |||
| Open | $10.74 | 52 Week Low | $ | |||
| Day High | $11.29 | P/E | N/A | |||
| Day Low | $10.62 | EPS | $ | |||
| Volume | 1,084,578 | |||||
| (NASDAQ: NBP) | Delayed: 1.22 -0.15 (10.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.37 | 52 Week High | $6.95 | |||
| Open | $1.39 | 52 Week Low | $6.95 | |||
| Day High | $1.39 | P/E | 0.57 | |||
| Day Low | $1.21 | EPS | $2.14 | |||
| Volume | 818,329 | |||||



